Evidence map›Paper›PMID 28349281›Full record

GuidelineInternational journal of clinical oncology2018

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

Toshiaki Watanabe, Kei Muro, Yoichi Ajioka, Yojiro Hashiguchi, Yoshinori Ito, Yutaka Saito, Tetsuya Hamaguchi, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara and 31 more

Open access · hybridAbstract readGuideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in International journal of clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 445 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
445citing papers in PubMed, 13 pooled it
97.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

445 citing papers in PubMed, 13 syntheses or guidelines pooled it, 2,484 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

385 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 1 country.

Toshiaki WatanabeDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. toshwatanabe@yahoo.co.jp.
Kei MuroDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Yojiro HashiguchiDepartment of Surgery, Teikyo University, Tokyo, Japan.
Yoshinori ItoDepartment of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yutaka SaitoEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Tetsuya HamaguchiDivision of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Megumi IshiguroDepartment of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Yukihide KanemitsuColorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Hiroshi KawanoDepartment of Gastroenterology, St. Mary's Hospital, Fukuoka, Japan.
Yusuke KinugasaDepartment of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Norihiro KokudoHepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Keiko MurofushiRadiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Takako NakajimaDepartment of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
Shiro OkaGastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
Yoshiharu SakaiDepartment of Surgery, Kyoto University, Kyoto, Japan.
Akihito TsujiDepartment of Clinical Oncology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.
Keisuke UeharaDivision of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hideki UenoDepartment of Surgery, National Defense Medical College, Saitama, Japan.
Kentaro YamazakiDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Masahiro YoshidaDepartment of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Ichikawa, Japan.
Takayuki YoshinoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Narikazu BokuDivision of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Takahiro FujimoriDiagnostic Pathology Center, Shinko Hospital, Kobe, Japan.
Michio ItabashiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Nobuo KoinumaDepartment of Health Administration and Policy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Takayuki MoritaDepartment of Surgery, Cancer Center, Aomori Prefectural Central Hospital, Aomori, Japan.
Genichi NishimuraDepartment of Surgery, Japanese Red Cross Kanazawa Hospital, Ishikawa, Japan.
Yuh SakataCEO, Misawa City Hospital, Misawa, Japan.
Yasuhiro ShimadaDivision of Clinical Oncolgy, Kochi Health Sciences Center, Kochi, Japan.
Keiichi TakahashiDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Osamu TsurutaDivision of GI Endoscopy, Kurume University School of Medicine, Fukuoka, Japan.
Toshiharu YamaguchiDepartment of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Naohiko YamaguchiLibrary of SEIREI SAKURA Citizen Hospital, Sakura, Japan.
Toshiaki TanakaDepartment of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Kenjiro KotakeDepartment of Surgery, Tochigi Cancer Center, Utsunomiya, Japan.
Kenichi SugiharaDepartment of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Japanese Society for Cancer of the Colon and Rectum
National Cancer Center Hospital East · JPShizuoka Cancer Center · JPTokyo Medical and Dental University · JPAichi Cancer Center · JPAomori Prefectural Central Hospital · JPKagawa University · JPKurume University · JPMisawa City Hospital · JPSeirei Sakura Citizen Hospital · JPSt. Marianna University School of Medicine · JPTokyo Metropolitan Komagome Hospital · JPTokyo National Hospital · JPTokyo Women's Medical University · JPKyoto University · JPNational Defense Medical College · JPNiigata University · JPShinko Hospital · JPSt Mary's Hospital · JPThe Cancer Institute Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2016 for the treatment of colorectal cancer (JSCCR Guidelines 2016) were prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding between health-care professionals and patients by making these Guidelines available to the general public. These Guidelines were prepared by consensus reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches, and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these Guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions held by the Guideline Committee, controversial issues were selected as Clinical Questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2016.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColonic NeoplasmsColorectal NeoplasmsDose Fractionation, RadiationHumansJapanLaparoscopyLiver NeoplasmsLymph Node ExcisionRectal NeoplasmsChemotherapyColorectal cancerEndoscopyGuidelineRadiotherapySurgery

Identifiers

PMID28349281
PMCPMC5809573
OpenAlexW1990423062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.